What is LRCX's health score?

LAM RESEARCH CORP (LRCX) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LRCX's estimated fair value?

Based on our 5-year discounted cash flow model, LAM RESEARCH CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is LRCX undervalued or overvalued?

Our model currently rates LRCX as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LRCX... Refresh in a moment for the full analysis.

LAM RESEARCH CORP (LRCX)

Technology Inconclusive inconclusive healthy

$318.18

Updated: 2026-05-31

TradeApes Score

Financial Strength

85 Strong

Operating Trend

60 Healthy

Relative Value

30 Weak

Capital Allocation

55 Mixed

Risk

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.